
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The Red Sea strategy: What does Israel stand to gain from recognizing Somaliland? - 2
Monetary Wellness: Planning Tips for Independence from the rat race - 3
Finding the Universe of Computer generated Reality: Individual Encounters - 4
Bondi Beach survivor criticizes police for inaction during terror attack - 5
Find the Marvels of the World with These Travels
Treasure trove found in Egyptian tomb solves ancient mystery
Jenny & Dave Marrs Mourn Loss of Former ‘Fixer to Fabulous: Italiano’ Guest
Doggie diversity in size and shape began at least 11,000 years ago
The Way to Fruitful Weight reduction: Individual Wellbeing Excursions
January full moon wows skywatchers with a striking 'Wolf Supermoon' (photos)
Barry Manilow reveals lung cancer diagnosis and plans to undergo surgery: 'It's pure luck' it was 'found so early'
Director of Swiss hospital describes the rush to treat the injured from Alpine resort bar fire
Hezbollah fires over 600 times at Israel, IDF troops over last 24 hours
Figure out how to Consolidate All encompassing Practices with a Degree in Brain research












